| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/20/2001 | WO2001068860A1 Antibodies to human cd154 |
| 09/20/2001 | WO2001068855A2 Gtp-binding protein gamma-12 subunit |
| 09/20/2001 | WO2001068852A2 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | WO2001068851A2 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | WO2001068848A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | WO2001068846A2 Transcription activator of the cited family |
| 09/20/2001 | WO2001068824A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 09/20/2001 | WO2001068805A2 Human olfactory receptors and genes encoding same |
| 09/20/2001 | WO2001068801A2 Single chain antibody against mutant p53 |
| 09/20/2001 | WO2001068711A1 Sensitive detection of wild-type and mutant egfr by specific elisa assays in any biological sample |
| 09/20/2001 | WO2001068710A1 Monoclonal antibodies to the human ldl receptor, their production and use |
| 09/20/2001 | WO2001068709A1 Antibodies that bind phosphatidyl serine and a method of their use |
| 09/20/2001 | WO2001068708A2 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068704A2 G-protein coupled receptors |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068696A1 Human immune response proteins |
| 09/20/2001 | WO2001068695A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 09/20/2001 | WO2001068682A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | WO2001068677A2 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 09/20/2001 | WO2001068666A1 Tcl1 enhances akt kinase activity and mediates its nuclear translocation |
| 09/20/2001 | WO2001068146A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 09/20/2001 | WO2001068134A2 Therapies that improve graft survival, using antibodies against a b7 antigen |
| 09/20/2001 | WO2001068133A1 Use of rapamycin and agents that inhibit b7 activity in immunomodulation |
| 09/20/2001 | WO2001068132A1 Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection |
| 09/20/2001 | WO2001068131A1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 09/20/2001 | WO2001068123A2 Monocyte chemoattractant activity of galectin-3 |
| 09/20/2001 | WO2001068122A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 09/20/2001 | WO2001068110A1 Method and apparatus for inducing a cellular response |
| 09/20/2001 | WO2001049745A9 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/20/2001 | WO2001030851A3 Idiotype vaccines |
| 09/20/2001 | WO2001019850A3 Nrage nucleic acids and polypeptides and uses thereof |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001016165A3 Apoptin-associating protein |
| 09/20/2001 | WO2001014424A3 Human ctla-4 antibodies and their uses |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | WO2000037491A3 Dnas encoding proteins with signal sequences |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | WO2000034436A3 Facs assisted methods for introducing individual chromosomes into cells |
| 09/20/2001 | WO1999040102A9 Novel molecules of the card-related protein family and uses thereof |
| 09/20/2001 | US20010023287 Induction of endhotelial procoagulant is inhibited and induction of fibrin deposition is enhanced; cytotoxicity and receptor binding activities unaffected; monoclonal antibody |
| 09/20/2001 | US20010022971 IBD-associated microbial nucleic acid molecules |
| 09/20/2001 | US20010022969 Sepsis therapy |
| 09/20/2001 | DE10013618A1 New polypeptides from Drosophila melanogaster have biological activity of peptide receptor, useful to find new compounds for plant protection and insecticides |
| 09/20/2001 | DE10013580A1 Rezeptor für Latrotoxin aus Insekten Receptor for Latrotoxin from insects |
| 09/20/2001 | DE10013286A1 New human humanized antibody that specifically binds to fibroblasts activating protein alpha, useful for treating cancer or tumor, and for imaging tumors associated with activated stromal fibroblasts, e.g. lung or breast cancer |
| 09/20/2001 | CA2539214A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534186A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534030A1 Screted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534018A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533991A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533903A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533831A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2531917A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2408175A1 Sensitive detection of wild-type and mutant egfr by specific elisa assays in any biological sample |
| 09/20/2001 | CA2403739A1 Three-dimensional model of a complex between a fc epsilon receptor alpha chain and a fc region of an ige antibody and uses thereof |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403084A1 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 09/20/2001 | CA2402940A1 G-protein coupled receptors |
| 09/20/2001 | CA2402877A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 09/20/2001 | CA2402855A1 Transcription transactivator protein |
| 09/20/2001 | CA2402772A1 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | CA2402729A1 Human immune response proteins |
| 09/20/2001 | CA2402721A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 09/20/2001 | CA2402614A1 Insulin homolog polypeptide zins4 |
| 09/20/2001 | CA2402530A1 Blocking leukocyte emigration and inflammation by interfering with cd99 |
| 09/20/2001 | CA2402248A1 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | CA2402086A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | CA2401448A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2401406A1 Human olfactory receptors and genes encoding same |
| 09/20/2001 | CA2401273A1 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | CA2401252A1 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | CA2400825A1 Three-dimensional model of a fc region of an ige antibody and uses thereof |
| 09/20/2001 | CA2400106A1 Antibodies to human cd154 |
| 09/20/2001 | CA2373414A1 A novel factor-h related protein 5 and antobodies thereto |
| 09/19/2001 | EP1134231A1 Antibody heavy chain variable domains against human dietary enzymes, and their uses |
| 09/19/2001 | EP1133995A2 Interleukin-1 inhibitors |
| 09/19/2001 | EP1133994A1 A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA" |
| 09/19/2001 | EP1133988A1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 09/19/2001 | EP1133693A1 Test kit and method of diagnosing severe acute pancreatitis |
| 09/19/2001 | EP1133572A2 Chlamydia pneumoniae genome sequence |
| 09/19/2001 | EP1133566A1 Dna encoding fusion proteins which are specifically cleavable by copper (ii) ions |
| 09/19/2001 | EP1133565A2 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 09/19/2001 | EP1133564A1 Zace1: a human metalloenzyme |
| 09/19/2001 | EP1133563A2 Methods and molecules relating to cd39-like polypeptides |
| 09/19/2001 | EP1133561A2 Protein fragments for use in protein targeting |
| 09/19/2001 | EP1133558A1 Compositions and methods for increasing bone mineralization |
| 09/19/2001 | EP1133557A2 Growth factor modulators |
| 09/19/2001 | EP1133523A1 Generation of antibodies using polynucleotide vaccination in avian species |
| 09/19/2001 | EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene |
| 09/19/2001 | EP1133515A1 Dna molecules encoding hg51, a g-protein-coupled receptor |
| 09/19/2001 | EP1133315A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 09/19/2001 | EP1133311A2 INFLUENCING OF ANGIGENESIS USING CD66a |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP0876509B1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 09/19/2001 | EP0754751B1 Novel deoxyribonuclease |
| 09/19/2001 | CN1313901A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313900A Novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 09/19/2001 | CN1313899A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them |